Leprosy in 21st century
DOI:
https://doi.org/10.66344/jpad.26.2.2016.47References
Rao P N, Jain S. Newer management options in leprosy. Indian J Dermatol. 2013;58:6-11.
World Health Organization. Global leprosy situation, weekly epidemiological record. 2015;36:461-76
Ghayas AS, Saaiq M, Mahmood-ur-Rahman. Clinical observations in leprosy cases treated at Diamer district of Gilgit-Baltistan, Pakistan. J Pak Med Assoc.2013;63:1415-7.
Singal A, Sonthalia S. Leprosy in postelimination era in India: Difficult journey ahead. Indian J Dermatol. 2013;58:443-6.
Han XY, Silva FJ. On the age of leprosy. PLoS Negl Trop Dis. 2014;8(2):e2544.
White C, Franco-Paredes C. Leprosy in the 21st century. Clin Microbiol Rev. 2015;28:80-94.
Spencer JS, Brennan PJ. The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy. Lepr Rev. 2011;82:344-57.
Geluk A, Duthie MS, Spencer JS. Postgenomic Mycobacterium leprae antigens for cellular and serological diagnosis of M. leprae exposure, infection and leprosy disease. Lepr Rev. 2011;82:402-21.
Duthie MS1, Balagon MF, Maghanoy A, Orcullo FM, Cang M, Dias RFet al. Rapid quantitative serological test for detection of infection with Mycobacterium leprae, the causative agent of leprosy. J Clin Microbiol. 2014;52:613-9.
Campos DC, Dutra AP, Suares VL, Carvalho PA, Camargo LM. New strategies for active finding of leprosy cases in the Amazonian region. Rev Soc Bras Med Trop. 2015;48:488-90.
Hacker MA, Duppre NC, Nery JA, Sales AM, Sarno EN. Characteristics of leprosy diagnosed through the surveillance of contacts: a comparison with index cases in Rio de Janeiro, 1987-2010. Mem Inst Oswaldo Cruz. 2012; 107:49-54.
Richardus JH, Oskam L. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis. Clin Dermatol. 2015;33:19-25.
Chaptini C, Marshman G. Leprosy: a review on elimination, reducing the disease burden, and future research. Lepr Rev. 2015;86:307-15.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
